The Tech Corridor pioneers of healthy ageing technology

16th July 2020

Technology has a key role to play in ensuring future generations age healthily

With dipping fertility rates set to leave countries around the world with much older populations, we take a look at some of the Tech Corridor innovators coming up with new ideas to enable healthy ageing.

Falling fertility rates mean nearly every country could have shrinking populations by the end of the century, according to a new study. Twenty three nations – including Spain and Japan – are expected to see populations halve by the year 2100, says the report published in The Lancet.

Described as “natural population decline”,  the falling fertility rate is nothing to do with sperm counts, but is said to be a conscious decision by women to have fewer children. With the planet already cracking under the pressure of the current population levels, having a natural decline over the coming decades may not be seen as such a bad thing, but as Prof Christopher Murray, director of the Institute for Health Metrics & Evaluation at the University of Washington told the BBC, the challenge will be the subsequent inverted age structure (more old people than young people).

This opens up many worrying questions: Who pays tax in a massively aged world? Who pays for healthcare for the elderly? Who looks after the elderly? Will people still be able to retire from work?

‘Ageing society’ is one of the UK’s four Grand Challenges – the strategic focus areas to put the UK at the forefront of the industries of the future, ensuring that the UK takes advantage of major global changes, improving people’s lives and the country’s productivity.

Technology will undoubtedly have a huge part to play in answering some of the questions raised by this inverted age society of the future. We have compiled some of the pioneering work already being undertaken by tech businesses, entrepreneurs and institutions in the Cambridge Norwich Tech Corridor region.

Tech Corridor healthy ageing pioneers

Glyconics:

Goal: Early identification of healthcare needs

A finalist in our 2019 Investment Catalyst programme, Glyconics is a Cambridge/Norwich based medtech business developing point-of-care diagnostic devices, initially focused on COPD and diabetes diagnostics.  Over 420 million people worldwide are currently living with diabetes and it is believed that one in two are undiagnosed. Left untreated diabetes can cause life threatening complications. Glyconics use infrared spectroscopy to analyse for markers of disease, which would enable healthcare providers to better anticipate future needs of patients.

Closed Loop Medicine

Goal: Reduce pressure on healthcare services

Cambridge based Closed Loop Medicine aims to tackle the challenge of overstretched healthcare services by digitally optimising the patient/doctor feedback loop. Using digital devices Closed Loop approach uses digital real time tracking to capture a patient’s true progress and allows doctors to administer tailored care solutions only when needed.

Decorte Future Industries 

Goal: Reduce staffing pressures in care homes

This Cambridge University spin out was recently awarded funding by Innovate UK to support R&D and trials to deploy a patent-pending exoskeleton, in care homes to monitor and empower the elderly and vulnerable. This particular project addresses, in the short term, the current Covid-19 crisis, and in the long term, the crisis in Care, where demand will outstrip supply in 2022.  Their intelligent clothing solution would allow single-platform remote monitoring of multimodal biometrics (vitals, including body-temperature, coughing) of the wearer. It further enhances the mobility of the user by allowing them to employ the same embedded hardware to remotely control devices through voice, gesture and touch commands, e.g. through touching their sleeve, using existing third-party AI.

Sea Hero Quest

Goal: Early detection of genetically predisposed medical conditions

Sea Quest Hero is an innovative mobile game which aims to detect people most at risk of Alzheimers.  The game, created by Deutsche Telekom in partnership with the University of East Anglia, Alzheimer’s Research UK, University College London (UCL), and game developers, Glitchers has been designed to help researchers better-understand dementia by seeing how the brain works in relation to spatial navigation.  “Dementia will affect 135 million people worldwide by 2050. We need to identify people earlier to reduce their risk of developing dementia in the future. Current diagnosis of dementia is strongly based on memory symptoms, which we know now are occurring when the disease is quite advanced. Instead, emerging evidence shows that subtle spatial navigation and awareness deficits can precede memory symptoms by many years.“, Lead researcher Prof Michael Hornberger, from UEA’s Norwich Medical School

e-surgery

Goal: Modernise prescription services

A Norwich based start up, e-surgery is an online pharmacy and prescriber.  They enable patients to access prescription medication for common conditions without needing to see a doctor. You simply go online, choose the treatment, answer a simple health questionnaire which is checked by their UK-based prescribers, and the medication gets sent to you in discreet, 100% recyclable and biodegradable packaging. They also offer a free Ask-A-Pharmacist service giving patients access to information directly from trained professionals, reducing the need to attend in person appointments.

Funding opportunities for health and care innovations in the Tech Corridor

If you have a business or a business idea which can help in the UK’s goal to help meet the needs of its aging society, then it is worth keeping an eye out for grants and funding which could help fast track your progress.

 

Overview:

UK registered businesses can apply for a share of up to £2 million to develop digital health technologies in partnership with organisations from EUREKA countries.

Details:

Innovate UK, part of UK Research and Innovation, is investing up to £2 million to fund collaborative research and development (CR&D) projects focused on industrial research.

We will fund digital health and smart device projects that promote healthy ageing. They must meet one or more of these themes:

  • robotics
  • augmented or artificial intelligence
  • software as a medical device
  • wearables
  • medical devices
  • diagnostics
  • imaging
  • data analytics
  • sensors
  • apps

Projects must include at least one partner from one of the participating countries of the EUREKA Network. These countries are:

France, Spain, Belgium, Luxembourg, Canada, Malta, Turkey, Austria

Project size

UK applicants can apply for total grant of up to £500,000 for each project.

Closing date: 5th August 2020

Apply here

**COMING UP**  Biomedical Catalyst 2020: round 1, early and late stage awards

UK registered SMEs can apply for a share of up to £30 million to develop a product or process that is an innovative solution to a health and care challenge.

These can include, for example:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

This competition combines the early and late stage strands of the Biomedical Catalyst.

Your project’s total eligible costs must be between £250,000 and £4 million.

  • Competition opens: Monday 27 July 2020
  • Competition closes: Wednesday 7 October 2020 11:00am

This funding is from Innovate UK, part of UK Research and Innovation.

More details